Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Preveceutical Medical Inc C.PREV

Alternate Symbol(s):  PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).


CSE:PREV - Post by User

Bullboard Posts
Comment by Cashmeoussideon Jan 16, 2019 9:49pm
42 Views
Post# 29243340

RE:RE:RE:RE:Lots of Advancements in R&D and

RE:RE:RE:RE:Lots of Advancements in R&D and Isn’t it obvious, what  they modified was the parties named under order and the length of time of the order. Think about your interpretation, if BCSC is choosing to extend the order against the relevant Bridgemark parties for wrongdoing related to their purchase and sale of securities, why would they let them continue to sell some of the securities that they acquired in relation to the alleged wrongdoing?  How would it make sense that they are prevented from continuing wrongdoing against only the 4 issuers (companies) that continue to be prohibited under the order because those 4 may have participated in the same wrongdoing, and yet let them potentially do more harm against issuers that are now released from the investigation? Think. And even if you come up with a weird opinion or argument to the contrary, you can’t ignore what they said, which is not how you’ve interpreted it.


CanadaCoin wrote: "The relevant Bridgemark parties can’t buy or sell the remaining 30,000,000 shares since the BCSC extended the order against them."

Yes, the order was extended to April 2019, but why are you choosing to ignore the fact that the BCSC also "modified" the order?? 

Please refer back to my original post on this subject for further clarification. If I am wrong in this....I'll admit it. But you have posted nothing from the report to properly refute me. 



Cashmeousside wrote:
itwillgo1 wrote: Mary do you know if the remaining 30,000,000 shares issued as part of the "consulting agreement" are still available to trade by Bridegemark?


The relevant Bridgemark parties can’t buy or sell the remaining 30,000,000 shares since the BCSC extended the order against them.  CanadaCoin wants you to believe that Bridgemark can dump these shares and are only restricted from the 4 companies that are still under investigation, but he completely misinterpreted BCSC’s wording (or is just confusing you on purpose, either/or).  They’re restricted from buying or selling shares issues under the consultant exemption of any company under the CSE, which includes those 30,000,000.  PREV is suing those Bridgemark parties so they can’t dump them, and that’s a separate action, but the fact that the BCSC is temporarily ordering them not to touch those shares suggests they have reason to believe those Bridgemark members committed wrongdoing, making chances good that PREV will win against them and Bridgemark will have to return them to PREV.  Until that happens, they’re locked down.




Bullboard Posts